|
A (b)(6) ab result was reported on a blood sample tested with the alere determine hiv 1/2 ag/ab combo.The patient was confirmed (b)(6) by (b)(6), 4th generation eia, and rna pcr.There is insufficient information to determine if a malfunction occurred.The patient gender, pregnancy status, treatment and patient outcome were unknown.At the time of the event there was no indication of a product malfunction based on the information provided and assessed by alere (b)(4); however, this mdr is a retrospective filing in response to an observation from an fda inspection conducted february 26th to march 2nd, 2018 at alere (b)(4).
|